Sugammadex Injection
Product Images NDC 0264-8200

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 0264-8200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sugammadex Injection 2 mL Ndc 1)

Chemical structure of sugammadex showing a cyclic molecule with multiple sodium carboxylate groups and thioether side chains. The structure depicts the macromolecular arrangement characteristic of sugammadex.*

FDA Label Image

Structural Formula (Sugammadex Injection 2 mL Ndc 2)

Chemical structure diagram of sugammadex depicting the molecular arrangement and bonding of its cyclic oligosaccharide components, including multiple hydroxyl, carboxylate, and thiol groups.*

FDA Label Image

Figure 1 Illustration (Sugammadex Injection 2 mL Ndc 3)

A cumulative recovery rate chart comparing recovery times of Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg following Rocuronium administration. The X-axis represents time to recovery in minutes up to 120 minutes, and the Y-axis shows cumulative recovery rate from 0 to 1. The graph includes median and quartile values of recovery times for Sugammadex and Neostigmine with censored observations noted.*

FDA Label Image

Figure 2 Illustration (Sugammadex Injection 2 mL Ndc 4)

A line graph comparing the cumulative recovery rate over time (up to 120 minutes) between Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg following Vecuronium use. The y-axis represents cumulative recovery rate (0 to 1.0), and the x-axis shows time to recovery in minutes. The legend indicates median recovery times for Sugammadex (2.1 minutes) and Neostigmine (29.0 minutes), with data based on product-limit estimates and censored observations noted.*

FDA Label Image

Ds0200 Vial Label (Sugammadex Injection 2 mL Ndc 5)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) in a 2 mL single-dose vial. The label includes instructions for intravenous use only, storage conditions, and notes to discard unused portions. Distributed by B. Braun Medical Inc., the product is made in Italy. The label also lists lot and expiration date fields, bar code, and NDC 0264-8200.*

FDA Label Image

Ds0200 10 Count Box (Sugammadex Injection 2 mL Ndc 6)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) by B. Braun Medical Inc. The label indicates it is for intravenous use only and contains 10 single-dose 2 mL vials. Storage instructions, dosage warnings, and barcodes are also visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.